Review

Research progress of PI3K/Akt/mTOR signaling pathway and mTOR inhibitors in urologic malignancies

Expand
  • Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China

Online published: 2012-06-01

Supported by

Shanghai Natural Science Foundation,10411960000

Abstract

PI3K/Akt/mTOR signaling pathway plays a vital role in the angiogenesis, protein synthesis, cell growth and metabolism, and dysregulation of this pathway has been found in many substantive malignant tumors. In recent years, the inhibitors of PI3K/Akt/mTOR signaling pathway have been developed in succession, which have exhibited definite clinical effects on advanced renal cell carcinoma. As a result, further research on this pathway and its inhibitors, particularly their applications in urologic malignancies, has become one of the hot research areas. This paper focuses on the mechanism of PI3K/Akt/mTOR signaling pathway and its roles in the development of tumors, and the research progress of mTOR inhibitors in urologic malignancies is also reviewed.

Cite this article

SU Heng-chuan, SUN Fu-kang . Research progress of PI3K/Akt/mTOR signaling pathway and mTOR inhibitors in urologic malignancies[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2012 , 32(5) : 674 . DOI: 10.3969/j.issn.1674-8115.2012.05.032

Outlines

/